
Latest in VectorY Therapeutics
EUBizNews Editorial••5 min read
VectorY secures €30 million EIB loan to accelerate neurodegenerative disease treatments
Amsterdam-based VectorY Therapeutics receives €30 million from the European Investment Bank under the InvestEU programme to advance treatments for ALS and Huntington’s disease.
